These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1092 related articles for article (PubMed ID: 11962515)

  • 1. Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives.
    Mauri JK; Lasek W; Górska A; Switaj T; Wamil M; Młynarczuk I; Kazimierczuk Z
    Anticancer Drug Des; 2001; 16(2-3):73-80. PubMed ID: 11962515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adamantylsulfanyl- and N-adamantylcarboxamido-derivatives of heterocycles and phenols: synthesis, crystal structure, tumor necrosis factor-alpha production-enhancing properties, and theoretical considerations.
    Maurin JK; Lasek W; Górska A; Switaj T; Jakubowska AB; Kazimierczuk Z
    Chem Biodivers; 2004 Oct; 1(10):1498-512. PubMed ID: 17191793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of TNF-alpha production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy.
    Lasek W; Switaj T; Sieńko J; Kasprzycka M; Basak G; Mikłaszewicz P; Maj M; Nowis D; Grzela T; Gołab J; Młynarczuk I; Jalili A; Kamińska B; Dziembowska M; Czajkowski K; Nowaczyk M; Górska A; Kazimierczuk Z
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):213-22. PubMed ID: 12203103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological properties of S-adamantylated heterocyclic compounds.
    Górska A; Switaj T; Młynarczukh I; Lasek W; Kazimierczuk Z
    Acta Pol Pharm; 2002; 59(6):415-7. PubMed ID: 12669761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha.
    Kazimierczuk Z; Górska A; Switaj T; Lasek W
    Bioorg Med Chem Lett; 2001 May; 11(9):1197-200. PubMed ID: 11354376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha production-enhancing activity of 2-(1-adamantylamino)-6-methylpyridine (AdAMP) in cultures of human normal and neoplastic cells.
    Hareng L; Lasek W; Switaj T; Sienko J; Jakubowska AB; Nowaczyk M; Kasprzycka M; Kazimierczuk Z
    Anticancer Res; 2006; 26(2A):1209-15. PubMed ID: 16619526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
    Sorensen B; Winn M; Rohde J; Shuai Q; Wang J; Fung S; Monzon K; Chiou W; Stolarik D; Imade H; Pan L; Deng X; Chovan L; Longenecker K; Judge R; Qin W; Brune M; Camp H; Frevert EU; Jacobson P; Link JT
    Bioorg Med Chem Lett; 2007 Jan; 17(2):527-32. PubMed ID: 17070044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation.
    Patel JR; Shuai Q; Dinges J; Winn M; Pliushchev M; Fung S; Monzon K; Chiou W; Wang J; Pan L; Wagaw S; Engstrom K; Kerdesky FA; Longenecker K; Judge R; Qin W; Imade HM; Stolarik D; Beno DW; Brune M; Chovan LE; Sham HL; Jacobson P; Link JT
    Bioorg Med Chem Lett; 2007 Feb; 17(3):750-5. PubMed ID: 17110106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyric acid enhances in vivo expression of hTNF-alpha in transduced melanoma cell line.
    Giermasz A; Grzela T; Nowis D; Makowski M; Czajka A; Stoklosa T; Lasek W; Dabrowsk A; Wiznerowicz M; Mackiewicz A; Jakóbisiak M
    Anticancer Res; 2001; 21(6A):4001-4. PubMed ID: 11911283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.
    Kadi AA; El-Brollosy NR; Al-Deeb OA; Habib EE; Ibrahim TM; El-Emam AA
    Eur J Med Chem; 2007 Feb; 42(2):235-42. PubMed ID: 17129641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids.
    Barbarić M; Ursić S; Pilepić V; Zorc B; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; Snoeck R; Andrei G; Balzarini J; De Clercq E; Mintas M
    J Med Chem; 2005 Feb; 48(3):884-7. PubMed ID: 15689173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of aminoadamantane derivatives for in vitro anti-HIV and antitumor activities.
    da Settimo A; Marini AM; Primofiore G; Da Settimo F
    Farmaco; 1995 May; 50(5):321-6. PubMed ID: 7626166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.
    Brugel TA; Maier JA; Clark MP; Sabat M; Golebiowski A; Bookland RG; Laufersweiler MJ; Laughlin SK; Vanrens JC; De B; Hsieh LC; Mekel MJ; Janusz MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3510-3. PubMed ID: 16632356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
    Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
    J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure of some alpha,beta-unsaturated amidoesters--Part I.
    Najman L; Główka ML
    Acta Pol Pharm; 1990; 47(1-2):35-8. PubMed ID: 12959257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.
    Dawson MI; Harris DL; Liu G; Hobbs PD; Lange CW; Jong L; Bruey-Sedano N; James SY; Zhang XK; Peterson VJ; Leid M; Farhana L; Rishi AK; Fontana JA
    J Med Chem; 2004 Jul; 47(14):3518-36. PubMed ID: 15214780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2.
    Maier JA; Brugel TA; Clark MP; Sabat M; Golebiowski A; Bookland RG; Laufersweiler MJ; Laughlin SK; Vanrens JC; De B; Hsieh LC; Brown KK; Juergens K; Walter RL; Janusz MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3514-8. PubMed ID: 16632350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state and solution studies of a tetrameric capsule and its guests.
    Johnson DW; Hof F; Iovine PM; Nuckolls C; Rebek J
    Angew Chem Int Ed Engl; 2002 Oct; 41(20):3793-6. PubMed ID: 12386850
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
    Horvat S; Mlinarić-Majerski K; Glavas-Obrovac L; Jakas A; Veljković J; Marczi S; Kragol G; Roscić M; Matković M; Milostić-Srb A
    J Med Chem; 2006 Jun; 49(11):3136-42. PubMed ID: 16722632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.